Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Executive Officer sold 7,615 shares at an average $194.59 ($1,481,811)
  10. 4 Open-market sale EVP, Chief Financial Officer sold 977 shares at an average $194.59 ($190,113)
  11. 4 Open-market sale EVP, Chief Commercial Officer sold 1,476 shares at an average $194.59 ($287,215)
  12. 4 Open-market sale President sold 2,392 shares at an average $194.59 ($465,464)
  13. 4 Open-market sale CMO & EVP Dev & Med Affairs sold 4,294 shares at an average $197.12 ($846,450)
  14. 4 Open-market sale EVP, CLO & Secretary sold 3,500 shares at $210.00 ($735,000)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale CMO & EVP Dev & Med Affairs sold 18,072 shares at $200.00 ($3,614,400)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 47 · 936 filings